Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer (original) (raw)
Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers
Ricardo Guijarro
Oncotarget, 2014
View PDFchevron_right
Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis
Zhaojin Chen
Oncotarget, 2018
View PDFchevron_right
Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non-Small Cell Lung Cancer
Khalid Al-shibli
Clinical Cancer Research, 2008
View PDFchevron_right
The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival
Khalid Al-shibli
British Journal of Cancer, 2016
View PDFchevron_right
Relationship between tumor infiltrating lymphocytes (Tils) and neutrophil-lymphocyte ratio (NLR) as a prognostic factor in patients with advanced non-small cell lung cancer
Martin Paradelo
Journal of Clinical Oncology, 2016
View PDFchevron_right
Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer
Yanqi Huang
Frontiers in Immunology, 2022
View PDFchevron_right
Tumor infiltrating T cells influence prognosis in stage I–III non-small cell lung cancer
Arik Schulze
Journal of Thoracic Disease, 2020
View PDFchevron_right
CD45RO+ Memory T Lymphocytes — a Candidate Marker for TNM-Immunoscore in Squamous Non–Small Cell Lung Cancer
Khalid Al-shibli
Neoplasia, 2015
View PDFchevron_right
Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study
marc vooijs
Cancers, 2021
View PDFchevron_right
Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-Analysis
yili wang
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015
View PDFchevron_right
The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer
Qiang Pu
BMC Cancer, 2010
View PDFchevron_right
Cell by cell immuno- and cancer marker profiling of non-small cell lung cancer tissue: Checkpoint marker expression on CD103+, CD4+ T-cells predicts circulating tumor cells
Keith Shults
Translational Oncology
View PDFchevron_right
Tumour-infiltrating CD8+ lymphocytes as a prognostic marker in colorectal cancer: A retrospective, pooled analysis of the QUASAR2 and VICTOR trials
Dahmane Oukrif
Journal of Clinical Oncology, 2018
View PDFchevron_right
Tumor-infiltrating lymphocytes (TILs) density as prognostic determinant in stage II colorectal cancer
Cristiana Lo Nigro
Annals of Oncology, 2016
View PDFchevron_right
Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer
Vera Donnenberg
Cancer Immunology, Immunotherapy, 2011
View PDFchevron_right
The Immune Landscape of Non-Small-Cell Lung Cancer. Utility of Cytologic and Histologic Samples Obtained through Minimally Invasive Pulmonary Procedures
Alexander Chen
American journal of respiratory and critical care medicine, 2018
View PDFchevron_right
PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC
Xihui Lin
PloS one, 2016
View PDFchevron_right
Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis
Rene Michel
Canadian journal of surgery. Journal canadien de chirurgie, 2001
View PDFchevron_right
Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer
Robert West
Journal of the National Cancer Institute, 2015
View PDFchevron_right
Immune Cell Composition in Human Non-small Cell Lung Cancer
Branislava Stankovic
Frontiers in Immunology, 2019
View PDFchevron_right
Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study
Kosei Yasumoto
The Annals of Thoracic Surgery, 2003
View PDFchevron_right
Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers
Ivana Catacchio
Translational oncology, 2018
View PDFchevron_right
Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients
Ricardo Guijarro
OncoImmunology, 2016
View PDFchevron_right
Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer
Ralph Schmid
EBioMedicine, 2021
View PDFchevron_right
Tumor-Infiltrantig Lymphocytes Density as Determinant in Early Stage Colorectal Cancer Prognosis: A Single Centre Pilot Study
Daniela Vivenza
Radiotherapy and Clinical Oncology, 2019
View PDFchevron_right
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
Elin Richardsen
Neoplasia, 2019
View PDFchevron_right
Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: A multicenter prospective study. Commentary
Kosei Yasumoto
The Annals of Thoracic Surgery, 2003
View PDFchevron_right
Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
Kay Lawson
British Journal of Cancer
View PDFchevron_right
Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer
Kong-nan Zhao
Frontiers in Immunology, 2019
View PDFchevron_right
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Meso...
Andrea Vingiani
Advances in anatomic pathology, 2017
View PDFchevron_right
The Non–Small Cell Lung Cancer Immune Contexture. A Major Determinant of Tumor Characteristics and Patient Outcome
Sacha Gnjatic
American Journal of Respiratory and Critical Care Medicine, 2015
View PDFchevron_right
Blood immune cell biomarkers in lung cancer
Dagmar Riemann
Clinical and Experimental Immunology, 2018
View PDFchevron_right